Le Lézard
Classified in: Health
Subjects: AWD, WOM

U.S. Institute of Peace Opens Nominations for 2024 Women Building Peace Award


WASHINGTON, April 22, 2024 /PRNewswire/ -- The U.S. Institute of Peace (USIP) announces nominations are open for the 2024 Women Building Peace Award. This prestigious annual award honors courageous women in civil society who are building peace in countries impacted by violent conflict.

Countless women risk their lives to create peace in their communities, leading movements for justice, security and inclusivity despite often being overlooked in their efforts. USIP is committed to doing more to support and celebrate these women and the impact they have as catalysts for change and agents of peace.

The nomination period will run until June 10, 2024. USIP invites organizations and people across the globe to take part in identifying and honoring exceptional women who have dedicated their lives to building peace. The awardee will be recognized at a ceremony in Washington, DC, and will receive a cash prize.

USIP strongly encourages nominations for women who have not been previously recognized for their peacebuilding work.

Nominations will be reviewed based on award criteria, including: the nominee's commitment to peace, her exceptional leadership, her outstanding practice in putting a peacebuilding plan into action, and the impact of her work. The 2024 award winner will be chosen by the Women Building Peace Council, a group of distinguished experts who advise USIP on matters of gender and peacebuilding.

Previous recipients of the Women Building Peace Award include Pétronille Vaweka of the Democratic Republic of the Congo, María Eugenia Mosquera Riascos of Colombia, Josephine Ekiru of Kenya and Rita Lopidia of South Sudan. Twenty-four other women have been recognized by USIP as finalists for the award over the past four years.

For information on the award and to nominate a woman peacebuilder, visit: www.usip.org/womenbuildingpeace.

For information on USIP, visit: https://www.usip.org/about.

SOURCE United States Institute of Peace


These press releases may also interest you

at 03:05
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global...

at 03:05
Lantern Pharma Inc. , a leading artificial intelligence (AI) oncology drug discovery and development company, today announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimize the development of...

at 03:00
Patients with spinal cord injury (SCI) could benefit from future treatment to repair nerve connections using red and near-infrared light....

at 03:00
A recent global survey conducted by the World Lupus Federation reported that 91% of survey respondents were taking or have taken oral steroids to treat their lupus. Over 7,700 people living with lupus from more than 100 countries participated in the...

at 02:11
Calliditas Therapeutics AB ("Calliditas") today announced data from the proof-of-concept Phase 2 trial evaluating setanaxib, its lead NOX enzyme inhibitor, in combination with pembrolizumab, in patients with squamous cell carcinoma of the head and...

at 00:01
The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation announced a new partnership to support critical scientific research and development (R&D) for global health. The partnership is focused on supporting science and...



News published on and distributed by: